BRIEF-Sucampo says to discontinue development of Cobiprostone for PPI-Refractory NERD/SGERD

* Sucampo reports top-line data from phase 2a study of

cobiprostone in patients with PPI-Refractory Non-Erosive Reflux

Disease (NERD) and Symptomatic Gastroesophageal Reflux Disease

(SGERD)

Read more